Impact of COVID-19 on incidence and outcomes of post-infarction mechanical complications in Europe.
Acute myocardial infarction
COVID-19
cardiac rupture
papillary muscle rupture
ventricular septal rupture
Journal
Interdisciplinary cardiovascular and thoracic surgery
ISSN: 2753-670X
Titre abrégé: Interdiscip Cardiovasc Thorac Surg
Pays: England
ID NLM: 9918540787006676
Informations de publication
Date de publication:
18 Dec 2023
18 Dec 2023
Historique:
received:
23
06
2023
revised:
07
10
2023
accepted:
17
12
2023
medline:
18
12
2023
pubmed:
18
12
2023
entrez:
18
12
2023
Statut:
aheadofprint
Résumé
Post-acute myocardial infarction mechanical complications (post-AMI MCs) represent rare but life-threatening conditions, including free-wall rupture, ventricular septal rupture, and papillary muscle rupture. During the COVID-19 pandemic, an overwhelming pressure on healthcare systems led to delayed and potentially suboptimal treatments for time-dependent conditions. As AMI-related hospitalizations decreased, limited information is available whether higher rates of post-AMI MCs and related deaths occurred in this setting. This study was aimed to assess how COVID-19 in Europe has impacted the incidence, treatment, and outcome of MCs. The CAUTION-COVID19 study is a multicentre retrospective study collecting 175 patients with post-AMI MCs in 18 centers from 6 European countries, aimed to compare the incidence of such events, related patients' characteristics, and outcomes, between the first year of pandemic and the two previous years. A non-significant increase in MCs was observed (OR = 1.15, 95%C.I. 0.85-1.57, p = 0.364), with stronger growth in ventricular septal rupture diagnoses (OR = 1.43, 95%C.I. 0.95-2.18, p = 0.090). No significant differences in treatment types and mortality were found between the two periods. In-hospital mortality was 50.9% and was higher for conservatively managed cases (90.9%) and lower for surgical patients (44.0%). Patients admitted during COVID-19 more frequently had late-presenting infarction (OR = 2.47, 95%C.I. 1.24-4.92, p = 0.010), more stable conditions (OR = 2.61, 95%C.I. 1.27-5.35, p = 0.009) and higher EuroSCORE II (OR = 1.04, 95%C.I. 1.01-1.06, p = 0.006). A non-significant increase in MCs incidence occurred during the first year of COVID-19, characterized by a significantly higher rate of late-presenting infarction, stable conditions and EuroSCORE-II if compared to pre-pandemic data, without affecting treatment and mortality.
Identifiants
pubmed: 38109676
pii: 7477688
doi: 10.1093/icvts/ivad198
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.